Evidence map›Paper›PMID 37208933›Full record

ArticleGlia2023

Chronic demyelination and myelin repair after spinal cord injury in mice: A potential link for glutamatergic axon activity.

Nicole Pukos, Christina M Marion, W David Arnold, Benjamin T Noble, Phillip G Popovich, Dana M McTigue

Open access · hybridAbstract read
In one paragraph

Article in Glia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. 5-HTGeroScience · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nicole PukosNeuroscience Graduate Program, Ohio State University, Columbus, Ohio, USA.
Christina M MarionBelford Center for Spinal Cord Injury, Ohio State University, Columbus, Ohio, USA.ORCID 0000-0003-0381-4109
W David ArnoldDepartment of Neuroscience, College of Medicine, Ohio State University, Columbus, Ohio, USA.
Benjamin T NobleNeuroscience Graduate Program, Ohio State University, Columbus, Ohio, USA.ORCID 0000-0002-8992-2479
Phillip G PopovichBelford Center for Spinal Cord Injury, Ohio State University, Columbus, Ohio, USA.ORCID 0000-0003-1329-7395
Dana M McTigueBelford Center for Spinal Cord Injury, Ohio State University, Columbus, Ohio, USA.ORCID 0000-0001-7066-9701
The Ohio State University · USThe Ohio State University Wexner Medical Center · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
Overcoming Neurogenic “Meta-Inflammation” to Promote Recovery After Spinal Cord InjuryR35NS111582 · NINDS · OHIO STATE UNIVERSITY · PI PHILLIP G POPOVICH · 2019 to 2026
$8.7M
Regulation of myelination after spinal cord injuryR01NS100522 · NINDS · OHIO STATE UNIVERSITY · PI MCTIGUE, DANA M · 2018 to 2022
$2.2M
Ohio State University Neuroscience Center Core-Core EP30NS104177 · NINDS · OHIO STATE UNIVERSITY · PI BROWN, ANTHONY · 2017 to 2020
$1.9M
Strategies to interrogate and enhance myelin remodeling in distal tissue after spinal cord injuryF32NS119371 · NINDS · OHIO STATE UNIVERSITY · PI MARION, CHRISTINA MARIE · 2020 to 2022
$116k
Age-Induced Disruptions in Remyelination After Spinal Cord InjuryF31NS115523 · NINDS · OHIO STATE UNIVERSITY · PI PUKOS, NICOLE · 2020 to 2021
$48k
NCI NIH HHS P30 CA016058NINDS NIH HHS F31 NS115523NINDS NIH HHS F32 NS119371NINDS NIH HHS P30 NS104177NINDS NIH HHS R01 NS100522NINDS NIH HHS R35 NS111582
6 · The paper itself

Abstract

Our prior work examining endogenous repair after spinal cord injury (SCI) in mice revealed that large numbers of new oligodendrocytes (OLs) are generated in the injured spinal cord, with peak oligodendrogenesis between 4 and 7 weeks post-injury (wpi). We also detected new myelin formation over 2 months post-injury (mpi). Our current work significantly extends these results, including quantification of new myelin through 6 mpi and concomitant examination of indices of demyelination. We also examined electrophysiological changes during peak oligogenesis and a potential mechanism driving OL progenitor cell (OPC) contact with axons. Results reveal peak in remyelination occurs during the 3rd mpi, and that myelin generation continues for at least 6 mpi. Further, motor evoked potentials significantly increased during peak remyelination, suggesting enhanced axon potential conduction. Interestingly, two indices of demyelination, nodal protein spreading and Nav1.2 upregulation, were also present chronically after SCI. Nav1.2 was expressed through 10 wpi and nodal protein disorganization was detectable throughout 6 mpi suggesting chronic demyelination, which was confirmed with EM. Thus, demyelination may continue chronically, which could trigger the long-term remyelination response. To examine a potential mechanism that may initiate post-injury myelination, we show that OPC processes contact glutamatergic axons in the injured spinal cord in an activity-dependent manner. Notably, these OPC/axon contacts were increased 2-fold when axons were activated chemogenetically, revealing a potential therapeutic target to enhance post-SCI myelin repair. Collectively, results show the surprisingly dynamic nature of the injured spinal cord over time and that the tissue may be amenable to treatments targeting chronic demyelination.

Indexed as

Demyelinating DiseasesSpinal Cord InjuriesAnimalsAxonsMiceMyelin SheathNodal ProteinOligodendrogliaSpinal CordNodal ProteindemyelinationDREADDsglutamatemyelin repairspinal cord injury

Identifiers

PMID37208933
PMCPMC10330449
OpenAlexW4377137961

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.